The Kidney Fibrosis Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Kidney Fibrosis Treatment Market?
The market size for kidney fibrosis treatment has experienced significant growth lately. The market, which was valued at $6.93 billion in 2024, is projected to increase to $7.58 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Kidney Fibrosis Treatment Industry?
The global kidney fibrosis treatment market is projected to reach $10.78 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.7%.
Download Your Free Sample of the 2025 Kidney Fibrosis Treatment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Kidney Fibrosis Treatment Market?
The key drivers in the kidney fibrosis treatment market are:
• Increasing prevalence of chronic kidney diseases
• Rising demand for advanced therapies for renal fibrosis management
• Growing awareness of early-stage kidney fibrosis detection
• Rising incidence of diabetes and hypertension.
Global Market Segmentation: Identifying Major Kidney Fibrosis Treatment Industry Segments
The kidney fibrosis treatment market covered in this report is segmented –
1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types
2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy
3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications
4) By End-User: Clinics, Research Center, Hospitals
Pre-order the 2025 Kidney Fibrosis Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Kidney Fibrosis Treatment Market?
The key trends in the kidney fibrosis treatment market are:
• Advancements in early detection and diagnostic tools are emerging trends in the kidney fibrosis treatment market.
• Gene therapy advancements are becoming a significant trend shaping the future.
• Technology integration in telemedicine and remote monitoring is becoming increasingly influential.
• The advancements in stem cell therapies and drug delivery systems are notable emerging trends.
Who Are the Top Competitors & Leading Players in the Kidney Fibrosis Treatment Market?
Major players in the kidney fibrosis treatment market are:
• F. Hoffman-La Roche Ltd.
• Merck & Co. Inc.
• Bayer AG
• AstraZeneca PLC
• Cara Therapeutics Inc.
• Gilead Sciences Inc.
• Novo Nordisk A/S
• Boehringer Ingelheim International GmbH
• Vertex Pharmaceuticals Incorporated
• Chinook Therapeutics Inc.
• Reata Pharmaceuticals Inc.
• Akebia Therapeutics Inc.
• Travere Therapeutics Inc.
• Insilico Medicine Inc.
• Tvardi Therapeutics Inc.
• ProKidney LLC
• Alentis Therapeutics AG
• La Jolla Pharmaceutical Company
• Galecto Biotech AB
• Purespring Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Kidney Fibrosis Treatment Market?
North America was the largest region in the kidney fibrosis treatment market in 2024
